2Boucher, BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr 79, 315–327.
3Teegarden, D (2006) . In Calcium and Human Health, pp. 401–409 [Weaver, C and Heaney, R, editors]. Totowa, NJ: Humana Press Inc.
4Mathieu, C, Gysemans, C, Giulietti, A, et al. . (2005) Vitamin D and diabetes. Diabetologia 48, 1247–1257.
5Mathieu, C, Van Etten, E, Decallonne, B, et al. . (2004) Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 89–90, 449–452.
6Hebert, SC, Brown, EM & Harris, HW (2004) Role of the Ca2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200, 295–302.
7Zierold, C, Mings, JA & Deluca, HF (2003) Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 88, 234–237.
8Heaney, RP (2003) Sensitivity of parathyroid hormone response to calcium intake. Am J Clin Nutr 78, 493–495.
9Harkness, L & Cromer, B (2005) Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporosis Int 16, 109–113.
10Krall, EA, Sahyoun, N, Tannenbaum, S, et al. . (1989) Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321, 1777–1783.
11Weaver, CM & Fleet, JC (2004) Vitamin D requirements: current and future. Am J Clin Nutr 80, 1735S–1739S.
12Nesby-O'Dell, S, Scanlon, KS, Cogswell, ME, et al. . (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76, 187–192.
13Holick, MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 1678S–1688S.
14Heaney, RP & Weaver, CM (2003) Calcium and vitamin D. Endocrinol Metab Clin North Am 32, 181–194, .
15Procopio, M & Borretta, G (2003) Derangement of glucose metabolism in hyperparathyroidism. J Endocrinol Invest 26, 1136–1142.
16Pittas, AG, Lau, J, Hu, FB, et al. . (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017–2029.
17Palomer, X, Gonzalez-Clemente, JM, Blanco-Vaca, F, et al. . (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10, 185–197.
18Choi, HK, Willett, WC, Stampfer, MJ, et al. . (2005) Dairy consumption and risk of type 2 diabetes mellitus in men – a prospective study. Arch Intern Med 165, 997–1003.
19Parikh, SJ & Yanovski, JA (2003) Calcium intake and adiposity. Am J Clin Nutr 77, 281–287.
20Teegarden, D (2005) The influence of dairy product consumption on body composition. J Nutr 135, 2749–2752.
21Lin, YC, Lyle, RM, McCabe, LD, et al. . (2000) Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women. J Am Coll Nutr 19, 754–760.
22Zemel, MB, Shi, H, Greer, B, et al. . (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132–1138.
23Barr, SI (2003) Increased dairy product or calcium intake: is body weight or composition affected in humans? J Nutr 133, 245S–248S.
24Shapses, SA, Heshka, S & Heymsfield, SB (2004) Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab 89, 632–637.
25Gunther, CW, Legowski, PA, Lyle, RM, et al. . (2005) Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr 81, 751–756.
26Teegarden, D, White, KM, Lyle, RM, et al. . (2008) Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566–1572.
27McGill, AT, Stewart, JM, Lithander, FE, et al. . (2008) Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 7, 4.
28Pfeifer, M, Begerow, B & Minne, HW (2002) Vitamin D and muscle function. Osteoporos Int 13, 187–194.
29Boland, R (1986) Role of vitamin D in skeletal muscle function. Endocr Rev 7, 434–448.
30Visser, M, Deeg, DJ & Lips, P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88, 5766–5772.
31Bischoff, HA, Stahelin, HB, Urscheler, N, et al. . (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80, 54–58.
32Bischoff-Ferrari, HA, Dietrich, T, Orav, EJ, et al. . (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged>or = 60 y. Am J Clin Nutr 80, 752–758.
33Pfeifer, M, Begerow, B, Minne, HW, et al. . (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109, 87–92.
34Mowe, M, Haug, E & Bohmer, T (1999) Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc 47, 220–226.
35Bischoff-Ferrari, HA, Dawson-Hughes, B, Willett, WC, et al. . (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291, 1999–2006.
36Arabi, A, Baddoura, R, Awada, H, et al. . (2006) Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone 39, 268–275.
37Sato, Y, Iwamoto, J, Kanoko, T, et al. . (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20, 187–192.
38Siddiqui, S, Chang, E, Zou, M, et al. . (2007) High dietary calcium and vitamin D effects on fat mass accretion and expression of liver enzymes in rats. FASEB J 21, A56.
39Endo, I, Inoue, D, Mitsui, T, et al. . (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144, 5138–5144.
40Liu, S, Song, Y, Ford, ES, et al. . (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28, 2926–2932.
41Pittas, AG, Dawson-Hughes, B, Li, T, et al. . (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656.
42Scragg, R, Sowers, M & Bell, C (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813–2818.
43Martins, D, Wolf, M, Pan, D, et al. . (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159–1165.
44Reis, JP, von Mühlen, D, Kritz-Silverstein, D, et al. . (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30, 1549–1555.
45Ford, ES, Ajani, UA, McGuire, LC, et al. . (2005) Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28, 1228–1230.
46Baynes, KCR, Boucher, BJ, Feskens, EJM, et al. . (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40, 344–347.
47Need, AG, O'Loughlin, PD, Horowitz, M, et al. . (2005) Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol 62, 738–741.
48Targher, G, Bertolini, L, Padovani, R, et al. . (2006) Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 65, 593–597.
49Scragg, R, Holdaway, I, Singh, V, et al. . (1995) Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27, 181–188.
50Chiu, KC, Chu, A, Go, VL, et al. . (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79, 820–825.
51Boucher, BJ, Mannan, N, Noonan, K, et al. . (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239–1245.
52McCarty, MF & Thomas, CA (2003) PTH excess may promote weight gain by impeding catecholamine-induced lipolysis – implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 61, 535–542.
53Bolland, MJ, Grey, AB, Gamble, GD, et al. . (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrin Metab 90, 1525–1530.
54Bell, NH, Epstein, S, Greene, A, et al. . (1985) Evidence for alteration of the vitamin D–endocrine system in obese subjects. J Clin Invest 76, 370–373.
55Atkinson, RL, Dahms, WT, Bray, GA, et al. . (1978) Parathyroid hormone levels in obesity: effects of intestinal bypass surgery. Miner Electrolyte Metab 1, 315–320.
56Pittas, AG, Harris, SS, Stark, PC, et al. . (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980–986.
57de Boer, IH, Tinker, LF, Connelly, S, et al. . (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 31, 701–707.
58Borissova, AM, Tankova, T, Kirilov, G, et al. . (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57, 258–261.
59Allegra, V, Luisetto, G, Mengozzi, G, et al. . (1994) Glucose-induced insulin secretion in uremia: role of 1α,25(HO)2-vitamin D3. Nephron 68, 41–47.
60Mak, RH (1998) 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53, 1353–1357.
61Orwoll, E, Riddle, M & Prince, M (1994) Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59, 1083–1087.
62Raghuramulu, N, Raghunath, M, Chandra, S, et al. . (1992) Vitamin D improves oral glucose tolerance and insulin secretion in human diabetes. J Clin Biochem Nutr 13, 45–51.
63Ayesha, I, Raghunath, M, Sesikeran, B, et al. . (1998) Effect of oral administration of vitamin D on glucose tolerance and insulin secretion in type 2 diabetes mellitus. Diabetes Nutr Metab 11, 261–265.
64Szathmary, EJ (1987) The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 75, 368–372.
65Iyengar, S, Hamman, RF, Marshall, JA, et al. . (1989) On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 6, 691–698.
66Baier, LJ, Dobberfuhl, AM, Pratley, RE, et al. . (1998) Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 83, 2993–2996.
67Hirai, M, Suzuki, S, Hinokio, Y, et al. . (1998) Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 41, 742–743.
68Hirai, M, Suzuki, S, Hinokio, Y, Hirai, A, et al. . (2000) Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 85, 1951–1953.
69Ye, WZ, Dubois-Laforgue, D, Bellanne-Chantelot, C, et al. . (2001) Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism 50, 366–369.
70Klupa, T, Malecki, M, Hanna, L, et al. . (1999) Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 141, 490–493.
71Oh, JY & Barrett-Connor, E (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51, 356–359.
72Malecki, MT, Frey, J, Moczulski, D, et al. . (2003) Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 111, 505–509.
73Ortlepp, JR, Metrikat, J, Albrecht, M, et al. . (2003) The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20, 451–454.
74Ye, WZ, Reis, AF, Dubois-Laforgue, D, et al. . (2001) Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 145, 181–186.
75Malecki, MT, Klupa, T, Wolkow, P, et al. . (2003) Association study of the vitamin D: 1α-hydroxylase (CYP1α) gene and type 2 diabetes mellitus in a Polish population. Diabetes Metab 29, 119–124.
76Smogorzewski, M, Zayed, M, Zhang, YB, et al. . (1993) Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 264, H1998–H2006.
77Ni, Z, Smogorzewski, M & Massry, SG (1994) Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 135, 1837–1844.
78Christakos, S, Dhawan, P, Liu, Y, et al. . (2003) New insights into the mechanisms of vitamin D action. J Cell Biochem 88, 695–705.
79Zehnder, D, Bland, R, Williams, MC, et al. . (2001) Extrarenal expression of 25-hydroxyvitamin D(3)-1α-hydroxylase. J Clin Endocrinol Metab 86, 888–894.
80Flanagan, JN, Wang, L, Tangpricha, V, et al. . (2003) Regulation of the 25-hydroxyvitamin D-1α-hydroxylase gene and its splice variant. Recent results. Cancer Res 164, 157–167.
81Li, J, Byrne, ME, Chang, E, et al. . (2008) 1α-25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem 112, 122–126.
82Ishida, H, Suzuki, K, Someya, Y, et al. . (1993) Possible compensatory role of parathyroid hormone-related peptide on maintenance of calcium homeostasis in patients with non-insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 129, 519–524.
83Kadowaki, S & Norman, AW (1984) Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73, 759–766.
84Bourlon, PM, Faure-Dussert, A, Billaudel, B, et al. . (1996) Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3. J Endocrinol 148, 223–232.
85Bourlon, PM, Billaudel, B & Faure-Dussert, A (1999) Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160, 87–95.
86Billaudel, BJ, Bourlon, PM, Sutter, BC, et al. . (1995) Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 18, 673–682.
87Bourlon, PM, Faure-Dussert, A & Billaudel, B (1997) Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 121, 751–758.
88Bland, R, Markovic, D, Hills, CE, et al. . (2004) Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89–90, 121–125.
89Huang, Y, Ishizuka, T, Miura, A, et al. . (2002) Effect of 1α,25-dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes. Diabetes Res Clin Pract 55, 175–183.
90Maestro, B, Davila, N, Carranza, MC, et al. . (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223–230.
91Maestro, B, Campion, J, Davila, N, et al. . (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383–391.
92Pepe, J, Romagnoli, E, Nofroni, I, et al. . (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 16, 805–812.
93Teegarden, D, Legowski, P, Gunther, CW, et al. . (2005) Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss. J Clin Endocrinol Metab 90, 5127–5133.
94Kumar, S, Olukoga, AO, Gordon, C, et al. . (1994) Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40, 47–53.
95Malecki, MT, Klupa, T, Wanic, K, et al. . (2002) Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract 57, 99–104.
96Taylor, WH & Khaleeli, AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17, 175–180.
97Chiu, KC, Chuang, LM, Lee, NP, et al. . (2000) Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49, 1501–1505.
98Thomas, DM, Rogers, SD, Sleeman, MW, et al. . (1995) Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line. J Mol Endocrinol 14, 263–275.
99Reusch, JE, Begum, N, Sussman, KE, et al. . (1991) Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 129, 3269–3273.
100Perna, AF, Fadda, GZ, Zhou, XJ, et al. . (1990) Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 259, F210–F216.
101Chang, E, Donkin, S & Teegarden, D (2007) Parathyroid hormone modulates insulin-stimulated glucose uptake in differentiated adipocytes. FASEB J 21, A1111.
102Zhang, Z, Yuan, W, Sun, L, et al. . (2007) 1,25-Dihydroxyvitamin D3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int 72, 193–201.
103Sun, J, Kong, J, Duan, Y, et al. . (2006) Increased NF-κB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291, E315–E322.
104Adams, LS & Teegarden, D (2004) 1,25-Dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor κB. J Nutr 134, 2948–2952.
105Cohen-Lahav, M, Shany, S, Tobvin, D, et al. . (2006) Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol Dial Transplant 21, 889–897.
106Cohen-Lahav, M, Douvdevani, A, Chaimovitz, C, et al. . (2007) The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103, 558–562.
107Giulietti, A, van Etten, E, Overbergh, L, et al. . (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77, 47–57.
108Krishnan, AV, Moreno, J, Nonn, L, et al. . (2007) Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 22, Suppl. 2, V74–V80.
109Miele, C, Riboulet, A, Maitan, MA, et al. . (2003) Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C α-mediated mechanism. J Biol Chem 278, 47376–47387.
110Talmor, Y, Golan, E, Benchetrit, S, et al. . (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294, F1059–F1064.